Terms: = Kidney tumors AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD
35119 results:
1. Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue.
Connaughton M; Dabagh M
IEEE J Transl Eng Health Med; 2024; 12():413-434. PubMed ID: 38765886
[TBL] [Abstract] [Full Text] [Related]
2. Radix Actinidiae chinensis induces the autophagy and apoptosis in renal cell carcinoma cells.
Liu B; Yan Y; Zhang L
Eur J Med Res; 2024 May; 29(1):291. PubMed ID: 38764054
[TBL] [Abstract] [Full Text] [Related]
3. Risk Factors for Teicoplanin-Associated Acute kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin.
Morinaga Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
Biol Pharm Bull; 2024; 47(5):988-996. PubMed ID: 38763761
[TBL] [Abstract] [Full Text] [Related]
4. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Lin Z; Xiao S; Qi Y; Guo J; Lu L
J Cancer Res Clin Oncol; 2024 May; 150(5):262. PubMed ID: 38762825
[TBL] [Abstract] [Full Text] [Related]
5. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients.
Fu Y; Zhong J; Tan Y; Zheng T; Liu M; Wang G
Sci Rep; 2024 May; 14(1):11409. PubMed ID: 38762673
[TBL] [Abstract] [Full Text] [Related]
6. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract] [Full Text] [Related]
7. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
10. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
[TBL] [Abstract] [Full Text] [Related]
12. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
[TBL] [Abstract] [Full Text] [Related]
13. Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT.
Dai C; Xiong Y; Zhu P; Yao L; Lin J; Yao J; Zhang X; Huang R; Wang R; Hou J; Wang K; Shi Z; Chen F; Guo J; Zeng M; Zhou J; Wang S
Radiology; 2024 May; 311(2):e232178. PubMed ID: 38742970
[TBL] [Abstract] [Full Text] [Related]
14. Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
Lambertini L; Mari A; Sandulli A; Amparore D; Antonelli A; Barale M; Bove P; Brunocilla E; Capitanio U; DA Pozzo LF; DI Maida F; Grosso AA; Fiori C; Gontero P; Li Marzi V; Campi R; Longo N; Marchioni M; Montanari E; Montorsi F; Porpiglia F; Porreca A; Schiavina R; Simeone C; Siracusano S; Terrone C; Ficarra V; Minervini A
Minerva Urol Nephrol; 2024 Apr; 76(2):185-194. PubMed ID: 38742553
[TBL] [Abstract] [Full Text] [Related]
15. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
[TBL] [Abstract] [Full Text] [Related]
16. Acute Airway Obstruction: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient.
Aggarwal J; Kumar DJ; Rathore V; Mehta R; Kumar A; Ravina M
Exp Clin Transplant; 2024 Apr; 22(4):307-310. PubMed ID: 38742322
[TBL] [Abstract] [Full Text] [Related]
17. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract] [Full Text] [Related]
18. Predictors of renal function deterioration at one year after off-clamp non-renorrhaphy partial nephrectomy.
Nakamura M; Kameyama S; Tsuru I; Izumi T; Ono A; Teshima T; Inoue Y; Amakawa R; Inatsu H; Yoshimatsu T; Kusakabe M; Morikawa T; Shiga Y
PLoS One; 2024; 19(5):e0303104. PubMed ID: 38739585
[TBL] [Abstract] [Full Text] [Related]
19. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
[TBL] [Abstract] [Full Text] [Related]
20. SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma.
Xu X; Lin J; Wang J; Wang Y; Zhu Y; Wang J; Guo J
Hum Vaccin Immunother; 2024 Dec; 20(1):2350101. PubMed ID: 38738709
[TBL] [Abstract] [Full Text] [Related]
[Next]
